These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17364896)

  • 1. Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Piccinni MN; Peros E; Geroldi D; Fogari E; D'Angelo A
    Endothelium; 2007; 14(1):45-51. PubMed ID: 17364896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
    Derosa G; D'Angelo A; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; Cicero AF
    Heart Vessels; 2007 Nov; 22(6):361-70. PubMed ID: 18043992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects.
    Derosa G; D'Angelo A; Tinelli C; Devangelio E; Consoli A; Miccoli R; Penno G; Del Prato S; Paniga S; Cicero AF
    Diabetes Metab; 2007 Apr; 33(2):129-34. PubMed ID: 17320450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia.
    Derosa G; Maffioli P; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Mereu R; Palumbo I; Randazzo S; Cicero AF
    Clin Invest Med; 2009 Apr; 32(2):E124-32. PubMed ID: 19331801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
    Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-2 and -9 levels in obese patients.
    Derosa G; Ferrari I; D'Angelo A; Tinelli C; Salvadeo SA; Ciccarelli L; Piccinni MN; Gravina A; Ramondetti F; Maffioli P; Cicero AF
    Endothelium; 2008; 15(4):219-24. PubMed ID: 18663625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics.
    Kardeşler L; Biyikoğlu B; Cetinkalp S; Pitkala M; Sorsa T; Buduneli N
    Oral Dis; 2010 Jul; 16(5):476-81. PubMed ID: 20233316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.
    Lee SW; Song KE; Shin DS; Ahn SM; Ha ES; Kim DJ; Nam MS; Lee KW
    Diabetes Res Clin Pract; 2005 Aug; 69(2):175-9. PubMed ID: 16005367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
    Derosa G; D'Angelo A; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Tinelli C; Cicero AF
    Endothelium; 2006; 13(3):227-31. PubMed ID: 16840178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
    Kadoglou NP; Vrabas IS; Sailer N; Kapelouzou A; Fotiadis G; Noussios G; Karayannacos PE; Angelopoulou N
    Diabetes Metab; 2010 Apr; 36(2):144-51. PubMed ID: 20149706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow-velocity eccentric-only resistance training improves symptoms of type 2 diabetic mellitus patients by regulating plasma MMP-2 and -9.
    Qian Z; Ping L; Dongming X; Xuelin Z
    Medicine (Baltimore); 2024 Jul; 103(29):e38855. PubMed ID: 39029066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
    J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
    Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
    ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
    Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
    J Clin Pharm Ther; 2006 Aug; 31(4):375-83. PubMed ID: 16882108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes.
    Maxwell PR; Timms PM; Chandran S; Gordon D
    Diabet Med; 2001 Oct; 18(10):777-80. PubMed ID: 11678966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible risk factors of carotid artery atherosclerosis in the Japanese population: a primary prevention study in non-diabetic subjects.
    Okada M; Miida T; Hama H; Yata S; Sunaga T; Tsuda A; Saito H
    Intern Med; 2000 May; 39(5):362-8. PubMed ID: 10830174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma t-PA and PAI-1 antigen concentrations in non-insulin dependent diabetic patients: implication for diabetic retinopathy.
    Cho YW; Yang DH; Oh DY; Baick SH; Kim SK; Kim SJ; Hong SY
    Diabetes Res Clin Pract; 1994 Jan; 22(2-3):123-8. PubMed ID: 8200293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.